Packaged Foods and Meats

Moolec Science SA

Moolec Science Obtains Piggy Sooy Technology Patent

Moolec Science SA Shareholder Meeting Approves Business Merger Agreement

Moolec Science SA and Bioceres Group Reach All-Stock Transaction Merger

Moolec Science SA released FY2025 Semi-Annual Earnings on April 16 EST, with actual revenue of USD 4.2 M and EPS of USD -1.1186

Moolec Science SA released FY2025 Q2 earnings on April 16 (EST), actual revenue USD 2.643 M (forecast USD 1.315 M), actual EPS USD -0.623 (forecast USD -0.6)

Moolec Science SA released FY2025 Q1 earnings on January 31 (EST), actual revenue USD 1.557 M (forecast USD 1.309 M), actual EPS USD -0.4951 (forecast USD -0.7)

Moolec Science SA released FY2024 Q4 earnings on October 7 Pre-Market EST, actual revenue USD 1.523 M (forecast USD 1.255 M), actual EPS USD -0.7 (forecast USD -0.6)

Moolec Science SA released FY2024 earnings on October 7 Pre-Market EST, actual revenue USD 5.625 M (forecast USD 5.753 M), actual EPS USD -1.9308 (forecast USD -1.9)

Moolec Science SA released FY2024 Q3 earnings on June 28 Pre-Market EST, actual revenue USD 2.11 M (forecast USD 650 K), actual EPS USD -0.3712 (forecast USD -0.7)

Moolec Science SA released FY2024 9 Months Earnings on June 28 Pre-Market EST, actual revenue USD 4.102 M, actual EPS USD -1.2638

Moolec Science SA released FY2024 Semi-Annual earnings on March 13 Pre-Market EST, actual revenue USD 1.992M, actual EPS USD -0.8925

Moolec Science SA released FY2024 Q2 earnings on March 13 Pre-Market (EST), actual revenue USD 252.11 K (forecast USD 600 K), actual EPS USD -0.4717 (forecast USD -0.7)

Moolec Science SA released FY2024 Q1 earnings on January 22 Pre-Market EST, actual revenue USD 1.74 M (forecast USD 630 K), actual EPS USD -0.4208 (forecast USD -0.5)

Moolec Science SA released FY2023 Q4 earnings on October 30 After-Market EST, actual revenue USD 905.05 K (forecast USD 0), actual EPS USD -0.7262 (forecast USD -1.1)

Moolec Science SA released FY2023 Annual Earnings on October 30 After-Market EST, actual revenue USD 905.05 K (forecast USD 0), actual EPS USD -15.0259 (forecast USD -11.9)

Moolec Science SA released FY2022 9 Months Earnings on July 10, 2023 (EST) with actual revenue of USD 0 and EPS of USD -0.9704

Moolec Science SA released FY2022 Q3 earnings on July 10, 2023 (EST), with actual revenue of USD 0 and EPS of USD -0.3764

Moolec Science SA released FY2023 9 Months Earnings on July 10 After-Market EST, Actual Revenue: USD 0, Actual EPS: USD -15.7625

Moolec Science SA released FY2023 Q3 earnings on July 10 After-Market EST, actual revenue USD 0, actual EPS USD -0.0948

Moolec Science SA released FY2022 Q2 earnings on April 4, 2023 (EST) with actual revenue of USD 0 and EPS of USD -0.2969

Agape ATP

PicoCELA

Co-Diagnostics

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Netcapital

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Akanda

NewGenIvf

MLEC

LABU

SBIO

Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period | MLEC Stock News

StockTitan

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

SPDR S&P Biotech

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period | MLEC Stock News

VEGI

FTAG

Moolec Science SA (NASDAQ:MLEC) shares rose in premarket trading despite a weak broader market, following a breakthrough in molecular farming. The stock is up 0.99% at $8.17, but remains down 91.59% over the past year. Key resistance is at $9.50 and support at $7.00. The company's recent achievement in stable expression of bovine myoglobin in pea seeds could enhance its position in alternative proteins. However, momentum remains weak, indicating the rise may be a short-term bounce rather than a trend reversal.

benzinga_article

VanEck Agribusiness ETF

iShares MSCI Agriculture Producers ETF

Invesco DB Agriculture FD ETF

First Trust Indxx Global Agri

NASDAQ-100

NASDAQ Composite Index

S&P 500

Why Is Moolec Science Stock Up Despite Weak Market Sentiment?

RMBS

In the past hour, the overall market of US stocks has shown significant differentiation, with notable volatility in the technology and biopharmaceutical sectors. The strong rise of Moolec Science SA has attracted considerable capital inflow, while individual stocks like Rambus have faced substantial sell-offs, indicating a polarization of market sentiment. Short-term enthusiasm has increased among small-cap stocks, particularly with some thematic stocks performing actively, suggesting a rapid shift in capital preferences. Overall volatility is high, the market pace is fast, and investor sentiment is relatively tense. The stock with the largest movement in the past hour, Moolec Science SA, surged by 35.48%, becoming the market focus. The stock quickly rallied after the opening, attracting a large amount of short-term capital, indicating strong buying sentiment and potential for further increases. Strong stocks include: 1. Thryv: up 9.79%, driven by optimistic expectations for its business prospects. 2. Kala Pharmaceuticals: up 8.63%, standing out in the biopharmaceutical sector with market anticipation for its R&D progress. 3. Sumitomo Mitsui Financial Group: up 4.67%, benefiting from the recovery of the financial market with noticeable capital inflow. 4. Mitsubishi UFJ Financial Group: up 4.07%, with the overall strong performance of the financial sector boosting the stock's rise. 5. Shell: up 3.03%, with the market holding an optimistic view of its prospects against the backdrop of rising energy prices

Price Alert

Rambus

Vivakor

Amkor Tech

POET Tech

Celestica

Thryv

KALA BIO

Borealis Foods

NOVARTIS AG

Sumitomo Mitsui Financial

Mitsubishi UFJ Financial

Credo Tech

U Power

Cue BioPharma

Coreweave

Astera Labs

Shell

U.S. Stock Movement Update: Moolec Science surged 35.48%, Rambus plummeted 15.07%

VIVK

POET

KALA

SMFG

MUFG

In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology and pharmaceutical stocks performing particularly well. The strong rise of Moolec Science SA has attracted market attention, with an increase of 37.58%, indicating enthusiasm from short-term funds. On the other hand, individual stocks such as Rambus and Vivakor have experienced significant declines, dropping 15.08% and 13.10% respectively, reflecting fluctuations in market sentiment and caution among investors. Overall, it seems that short-term enthusiasm is switching between small-cap stocks and thematic stocks, with considerable volatility and complex investor sentiment. The notable increase of 37.58% in Moolec Science SA, the most active stock in the past hour, appears to be driven by market expectations for its new products, leading to a rapid influx of short-term funds and a warming of overall sentiment. In contrast, the decline of Rambus stands out sharply, with a drop of 15.08% reflecting market concerns about its future prospects and a clear outflow of funds. Strong stocks include: 1. KALA BIO: up 11.64%, driven by optimistic expectations for its new drug development. 2. Sumitomo Mitsui Financial: up 4.67%, performing well in the financial sector with stable fund inflows. 3. Mitsubishi UFJ Financial: up 4.07%, benefiting from the market's reassessment of financial stocks, with active short-term fund involvement

U.S. stock movement quick report: Moolec Science surged 37.58%, Rambus plummeted 15.08%, attracting market attention

MLECW

Moolec Science shares fell 10.01% to $9.80 despite a breakthrough in producing bovine myoglobin in pea seeds. The company's innovation, achieved through a 28-month research project, enhances its position in the alternative protein sector. However, weak long-term trends and a significant 12-month decline of 89.07% overshadowed this progress. The stock is trading 28.1% above its 20-day SMA but 49.7% below its 200-day SMA, indicating mixed signals. Moolec is set to report earnings on April 20, 2026, with revised EPS and revenue estimates.

What's Going On With Moolec Stock Today?

Agriculture Investment Group Corp. has acquired a controlling 65.1% stake in Moolec Science SA, effective April 1, 2026, by converting $9 million of preference shares into ordinary shares. This acquisition grants AIGC majority voting power and signifies a significant change in Moolec's shareholder structure. AIGC, based in the British Virgin Islands, focuses on agricultural investments and may review its position and purpose over time. The details were filed with the SEC on April 7, 2026.

TradingView

Agriculture Investment Group Corp. Takes Control at Moolec Science SA with 65.1% Stake

BDRX

AIXI

TNMG

In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology and healthcare sectors performing particularly well. Xiao I saw an increase of 15.07%, attracting market attention, as it seems that short-term funds are confident about its future prospects. Meanwhile, Biodexa Pharmaceuticals faced a significant setback, with a decline of 18.86%, indicating that investors have raised doubts about its fundamentals. Overall, market sentiment has been quite volatile, with short-term enthusiasm concentrated on a few strong stocks, and capital flows are constantly switching. The stock with the largest movement in the past hour, Xiao I, performed impressively in the market, with an increase of 15.07%. The strong rebound of this stock seems to have attracted a large influx of short-term funds, driving its price up rapidly, and market sentiment has thus become more active. Investors are full of expectations for its future technological applications, and trading enthusiasm has clearly increased in the short term. Strong stocks: 1. Humana: up 11.37%, recent market response to its new products has been positive, attracting considerable capital attention. 2. Sky Quarry: up 8.60%, the company's layout in the environmental protection field has sparked investor enthusiasm, with noticeable short-term capital inflow. 3. Unitedhealth: up 6.86%, performing outstandingly in the healthcare sector, with optimistic market expectations for its performance. 4. LZ Tech - B: up 4.68%, the stock's progress in technological innovation has drawn investor attention, with increased activity in the short term

Biodexa Pharmaceuticals

Xiao I

TNL Mediagene

Humana

ABVC BioPharma

Sky Quarry

Perfect Moment

Lion

Unitedhealth

LZ Tech - B

Maxeon Solar Tech

MAXEON SOLAR TECHNOLOGIES LTD

U.S. stock market movement update: Xiao I surged 15.07%, Biodexa Pharmaceuticals plummeted 18.86%

In the past hour, the overall market in the US stock market has shown a clear divergence, with technology and healthcare sectors performing particularly well. Xiao I led the way with a 16.56% increase, attracting significant short-term capital attention, indicating that market enthusiasm for the artificial intelligence sector remains high. Meanwhile, Biodexa Pharmaceuticals and TNL Mediagene experienced substantial declines, dropping 14.47% and 12.79% respectively, reflecting cautious sentiment among investors towards the biopharmaceutical sector. Overall, market volatility has increased, short-term enthusiasm has clearly risen, and capital flows are continuously adjusting. The most notable stock in the past hour was Xiao I, which performed impressively with a 16.56% increase. The strong rebound of this stock seems to be attributed to market recognition of its technological advancements, with the influx of short-term capital rapidly driving up its stock price and boosting the activity of related technology stocks. Strong stocks include: 1. Sky Quarry: up 11.40%, as recent market attention on its sustainable development projects has driven up its stock price. 2. Humana: up 10.71%, with the company's innovative products in the healthcare sector sparking investor enthusiasm and active short-term capital involvement. 3. Turbo Energy SA: up 7.17%, as the trend of energy transition has attracted significant capital inflow, resulting in outstanding performance

Turbo Energy SA

Faraday Future Intelligent Electric

U.S. stock market movement update: Xiao I surged 16.56%, Sky Quarry and Humana followed closely, while Biodexa Pharmaceuticals plummeted 14.47%

In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology stocks and energy stocks performing actively, and the capital flow seems to lean more towards short-term hot spots. Small-cap stocks and thematic stocks have experienced significant volatility, especially the strong rise of Xiao I and Sky Quarry, which has attracted considerable attention from short-term funds. Meanwhile, some pharmaceutical stocks such as Biodexa Pharmaceuticals and TNL Mediagene have faced significant selling pressure, reflecting the complexity of market sentiment. Overall, the short-term heat is changing frequently, and the market pace is relatively fast. In the past hour, the stock with the largest abnormal movement, Xiao I, rose by 15.43%, attracting strong attention in the market, with rapid capital inflow and heightened short-term sentiment, suggesting potential for further upward movement. Sky Quarry also performed well, with an increase of 11.80%, possibly due to the market's optimistic expectations for its future development prospects. Strong stocks include: 1. Humana: up 10.45%, with recent market attention on its product line and noticeable capital inflow. 2. Turbo Energy SA: up 8.47%, with short-term funds actively participating driven by the energy sector. 3. Battalion Oil: up 7.08%, benefiting from the rebound in oil prices, with optimistic market sentiment. 4. Unitedhealth: up 6.62%, as the healthcare sector continues to be favored by investors, with stable capital inflow

Battalion Oil

U.S. stock market movement report: Xiao I surged 15.43%, TNL Mediagene plummeted 14.35%

Moolec Science SA(MLEC.US)

Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period | MLEC Stock News

Why Is Moolec Science Stock Up Despite Weak Market Sentiment?

U.S. Stock Movement Update: Moolec Science surged 35.48%, Rambus plummeted 15.07%

U.S. stock movement quick report: Moolec Science surged 37.58%, Rambus plummeted 15.08%, attracting market attention

What's Going On With Moolec Stock Today?

Agriculture Investment Group Corp. Takes Control at Moolec Science SA with 65.1% Stake

U.S. stock market movement update: Xiao I surged 15.07%, Biodexa Pharmaceuticals plummeted 18.86%

U.S. stock market movement update: Xiao I surged 16.56%, Sky Quarry and Humana followed closely, while Biodexa Pharmaceuticals plummeted 14.47%

U.S. stock market movement report: Xiao I surged 15.43%, TNL Mediagene plummeted 14.35%